- G Medical Innovations Holdings Ltd's GMVD subsidiary, G Medical Tests and Services Inc, expanded its COVID-19 testing services to more than 150+ additional locations across California.
- The new testing sites include theme parks, schools, commercial properties, office complexes, public buildings, and mobile facilities.
- G Medical acquired the business conducting testing at the locations for a total of $5.2 million in cash, to be paid out in milestones.
- The new sites will enable the processing of more than 200,000 COVID-19 PCR and rapid antigen/flu tests, with anticipated revenues of $20 million.
- The company also reports it has repaid $2.5 million in cash on a $5 million convertible loan issued by Lind Partners.
- The need for convenient COVID-19 PCR, Rapid Antigen/Flu testing, personal healthcare monitoring continues along with the company's Prizma Care remote patient monitoring directly to consumers.
- Price Action: GMVD shares are up 7.64% at $2.96 during the market session on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in